KRAS Amplification in Metastatic Colon Cancer is Associated with a History of Inflammatory Bowel Disease and May Confer Resistance to anti-EGFR Therapy
暂无分享,去创建一个
Michael S. Landau | M. Nikiforova | R. Brand | D. Bartlett | A. Singhi | Somak Roy | N. Bahary | A. Zureikat | Abigail I. Wald | Kenneth K. Lee | M. Ongchin | H. Choudry | A. Paniccia | C. Kaya | J. Pingpank | C. Parseghian | J. Rhee | L. Favazza | J. Dueker | V. Gorantla | S. Proksell | Elyse R. Johnston